Moreover, IL-6 may promote TGFβ-dependent tumor growth and as a result, attenuation of TGFβ signaling may contribute to the reduced HCC progression in mouse livers after DEN injection32, 33. This evidence concerns the gene TGFB1 and hepatocellular carcinoma.